Electronic HBV Alert
OtherElectronic HBV Alert deployed in electronic medical charts of at risk patients
NCT Number: NCT04240678
Asian and Pacific Islander Americans at risk, but never tested for chronic hepatitis B have been randomized to receive an electronic alert in their electronic medical chart to remind primary care physicians to screen them for chronic hepatitis B.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Asian and Pacific Islanders (API) who have not yet received HBsAg testing. API will be identified using a novel algorithm which identifies them using their surname, language preference, country of origin.
-
Exclusion criteria
Previous HBsAg completion.
-
Electronic HBV Alert deployed in electronic medical charts of at risk patients
Time frame: up to 12 months
Number of patients who have completed the HBsAg test
Time frame: up to 12 months
Number of patients with testing positive for HBsAg
University of California, Davis
Other
The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00004850
Blood-Borne Infections, Communicable Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06422767
Blood-Borne Infections, Communicable Diseases
Austin, Texas, United States
View Trial DetailsNCT07637214
Blood-Borne Infections, Bronchial Diseases
Wuhan, Hubei, China
View Trial DetailsNCT05551273
Blood-Borne Infections, Communicable Diseases
San Diego, California, United States
View Trial Details